These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 19430299

  • 1. Implementation of novel pyrosequencing assays to screen for common mutations of BRAF and KRAS in a cohort of sporadic colorectal cancers.
    Packham D, Ward RL, Ap Lin V, Hawkins NJ, Hitchins MP.
    Diagn Mol Pathol; 2009 Jun; 18(2):62-71. PubMed ID: 19430299
    [Abstract] [Full Text] [Related]

  • 2. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.
    Seth R, Crook S, Ibrahem S, Fadhil W, Jackson D, Ilyas M.
    Gut; 2009 Sep; 58(9):1234-41. PubMed ID: 19474002
    [Abstract] [Full Text] [Related]

  • 3. Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing.
    Borràs E, Jurado I, Hernan I, Gamundi MJ, Dias M, Martí I, Mañé B, Arcusa A, Agúndez JA, Blanca M, Carballo M.
    BMC Cancer; 2011 Sep 24; 11():406. PubMed ID: 21943394
    [Abstract] [Full Text] [Related]

  • 4. Tumor heterogeneity revealed by KRAS, BRAF, and PIK3CA pyrosequencing: KRAS and PIK3CA intratumor mutation profile differences and their therapeutic implications.
    Kosmidou V, Oikonomou E, Vlassi M, Avlonitis S, Katseli A, Tsipras I, Mourtzoukou D, Kontogeorgos G, Zografos G, Pintzas A.
    Hum Mutat; 2014 Mar 24; 35(3):329-40. PubMed ID: 24352906
    [Abstract] [Full Text] [Related]

  • 5. Mutation analysis of BRAF exon 15 and KRAS codons 12 and 13 in Moroccan patients with colorectal cancer.
    Bennani B, Gilles S, Fina F, Nanni I, Ibrahimi SA, Riffi AA, Nejjari C, Benajeh DA, El Abkari M, Martin PM, Ouafik L.
    Int J Biol Markers; 2010 Mar 24; 25(4):179-84. PubMed ID: 21161938
    [Abstract] [Full Text] [Related]

  • 6. Comparative analysis of pyrosequencing and QMC-PCR in conjunction with high resolution melting for KRAS/BRAF mutation detection.
    Ibrahem S, Seth R, O'Sullivan B, Fadhil W, Taniere P, Ilyas M.
    Int J Exp Pathol; 2010 Dec 24; 91(6):500-5. PubMed ID: 21199003
    [Abstract] [Full Text] [Related]

  • 7. KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.
    Heideman DA, Lurkin I, Doeleman M, Smit EF, Verheul HM, Meijer GA, Snijders PJ, Thunnissen E, Zwarthoff EC.
    J Mol Diagn; 2012 Dec 24; 14(3):247-55. PubMed ID: 22425762
    [Abstract] [Full Text] [Related]

  • 8. The proto-oncogene KRAS and BRAF profiles and some clinical characteristics in colorectal cancer in the Turkish population.
    Ozen F, Ozdemir S, Zemheri E, Hacimuto G, Silan F, Ozdemir O.
    Genet Test Mol Biomarkers; 2013 Feb 24; 17(2):135-9. PubMed ID: 23297805
    [Abstract] [Full Text] [Related]

  • 9. Development of ultra-short PCR assay to reveal BRAF V600 mutation status in Thai colorectal cancer tissues.
    Chat-Uthai N, Vejvisithsakul P, Udommethaporn S, Meesiri P, Danthanawanit C, Wongchai Y, Teerapakpinyo C, Shuangshoti S, Poungvarin N.
    PLoS One; 2018 Feb 24; 13(6):e0198795. PubMed ID: 29879227
    [Abstract] [Full Text] [Related]

  • 10. Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer.
    Vaughn CP, Zobell SD, Furtado LV, Baker CL, Samowitz WS.
    Genes Chromosomes Cancer; 2011 May 24; 50(5):307-12. PubMed ID: 21305640
    [Abstract] [Full Text] [Related]

  • 11. KRAS gene mutation in a series of unselected colorectal carcinoma patients with prognostic morphological correlations: a pyrosequencing method improved by nested PCR.
    de Macêdo MP, de Melo FM, Lisboa BC, Andrade LD, de Souza Begnami MD, Junior SA, Ribeiro HS, Soares FA, Carraro DM, da Cunha IW.
    Exp Mol Pathol; 2015 Jun 24; 98(3):563-7. PubMed ID: 25835782
    [Abstract] [Full Text] [Related]

  • 12. Duplex reverse-hybridization assay for the simultaneous detection of KRAS/BRAF mutations in FFPE-extracted genomic DNA from colorectal cancer specimens.
    Buxhofer-Ausch V, Ausch C, Zeillinger R, Oberkanins C, Dandachi N, Reiner-Concin A, Kriegshäuser G.
    Dis Markers; 2013 Jun 24; 34(3):171-7. PubMed ID: 23324583
    [Abstract] [Full Text] [Related]

  • 13. Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patients.
    Mohamed Suhaimi NA, Foong YM, Lee DY, Phyo WM, Cima I, Lee EX, Goh WL, Lim WY, Chia KS, Kong SL, Gong M, Lim B, Hillmer AM, Koh PK, Ying JY, Tan MH.
    Mol Oncol; 2015 Apr 24; 9(4):850-60. PubMed ID: 25605225
    [Abstract] [Full Text] [Related]

  • 14. A new microarray substrate for ultra-sensitive genotyping of KRAS and BRAF gene variants in colorectal cancer.
    Galbiati S, Damin F, Pinzani P, Mancini I, Vinci S, Chiari M, Orlando C, Cremonesi L, Ferrari M.
    PLoS One; 2013 Apr 24; 8(3):e59939. PubMed ID: 23536897
    [Abstract] [Full Text] [Related]

  • 15. High sensitivity of reverse-hybridization methodology in the detection of KRAS mutations from formalin-fixed paraffin-embedded colorectal cancer samples.
    De Miglio MR, Mura A, Uras MG, Manca A, Contini M, Murgia L, Zinellu A, Sotgia S, Carru C, Massarelli G, Cossu-Rocca P.
    Diagn Mol Pathol; 2010 Dec 24; 19(4):201-8. PubMed ID: 21052001
    [Abstract] [Full Text] [Related]

  • 16. Metastatic colorectal cancer KRAS genotyping in routine practice: results and pitfalls.
    Lamy A, Blanchard F, Le Pessot F, Sesboüé R, Di Fiore F, Bossut J, Fiant E, Frébourg T, Sabourin JC.
    Mod Pathol; 2011 Aug 24; 24(8):1090-100. PubMed ID: 21516079
    [Abstract] [Full Text] [Related]

  • 17. Wobble-enhanced ARMS method for detection of KRAS and BRAF mutations.
    Hamfjord J, Stangeland AM, Skrede ML, Tveit KM, Ikdahl T, Kure EH.
    Diagn Mol Pathol; 2011 Sep 24; 20(3):158-65. PubMed ID: 21817902
    [Abstract] [Full Text] [Related]

  • 18. Distribution of some activating KRAS and BRAF mutations in Slovene patients with colorectal cancer.
    Ličar A, Cerkovnik P, Novaković S.
    Med Oncol; 2011 Dec 24; 28(4):1048-53. PubMed ID: 20645028
    [Abstract] [Full Text] [Related]

  • 19. Cycleave polymerase chain reaction method is practically applicable for V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)/V-raf murine sarcoma viral oncogene homolog B1 (BRAF) genotyping in colorectal cancer.
    Yokota T, Shibata N, Ura T, Takahari D, Shitara K, Muro K, Yatabe Y.
    Transl Res; 2010 Aug 24; 156(2):98-105. PubMed ID: 20627194
    [Abstract] [Full Text] [Related]

  • 20. High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer.
    Simi L, Pratesi N, Vignoli M, Sestini R, Cianchi F, Valanzano R, Nobili S, Mini E, Pazzagli M, Orlando C.
    Am J Clin Pathol; 2008 Aug 24; 130(2):247-53. PubMed ID: 18628094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.